Directory

>

Mel Hayes

avatar

Mel Hayes

Chief Operating Officer | Fulcrum Therapeutics

Boston, Massachusetts, United States

View contact details (it's free)

Mel Hayes

Summary

Mel Hayes is a seasoned Executive Leader with over 25 years of experience in the biotechnology and pharmaceutical industries. Currently serving as the Chief Operating Officer at Fulcrum Therapeutics, Mel has a proven track record in corporate strategy, commercial operations, and product launch across multiple therapeutic areas including hematology, cardiology, and neurology. With an MBA from Columbia University, Mel combines strong business acumen with deep technical knowledge, having successfully managed top-line revenue of specialty businesses exceeding $1.5 billion. Mel is known for fostering purpose-driven cultures and building diverse teams that excel in cross-functional collaboration. His strategic insights have driven success in both U.S. and global markets, making him a key player in the commercialization of innovative therapies. Beyond his professional achievements, Mel is passionate about mentoring emerging leaders in the biotech sector and advancing healthcare accessibility.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Leadership Development

Emerging Technologies

Organisational experience

Corporate Experience

Mel Hayes

Work Experience

company logo

Chief Operating Officer at

Fulcrum Therapeutics

July 2022 - Present

company logo

Chief Commercial Officer (CCO) at

Fulcrum Therapeutics

September 2021 - June 2022

💼

Principal Owner at

HKH Consulting Company Limited

March 2020 - August 2021

company logo

Global Head, Vice President, Commercial Hemophilia & Complement, Rare Blood Disorders at

Sanofi

January 2019 - February 2020

company logo

Head, VP US & Global Commercial Strategic Marketing, Hematology, Complement Inline and Pipeline at

Bioverativ, a Sanofi company

October 2017 - January 2019

company logo

SVP, Head, Global Marketing and Launch Excellence at

SHIRE LIMITED

June 2016 - October 2016

company logo

Vice President, Global Inhibitors & Hemophilia B, Hematology at

Baxalta

July 2015 - June 2016

company logo

Vice President, Global Hemophilia Marketing, Inhibitors & Hemophilia B Portfolio at

Baxter International Inc.

January 2014 - June 2015

company logo

Senior Director Portfolio and LCM Management, Hematology at

Bayer AG

January 2008 - December 2013

company logo

Executive Director, Global Brand Team Head-Parkinsons at

Bayer AG

January 2005 - January 2008

company logo

Director, Global Strategy & EU Operations, Multiple Sclerosis at

Bayer AG

January 2002 - January 2005

company logo

Senior Product Manager, Diabetes Franchise at

Bristol Myers Squibb

January 1999 - January 2002

company logo

Area Marketing Manager at

Bristol Myers Squibb

January 1998 - January 1999

company logo

Senior District Manager, East Texas at

Bristol Myers Squibb

January 1995 - January 1997

Logos provided by Logo.dev

Frequently Asked Questions about Mel Hayes

What is Mel Hayes email address?

Mel Hayes's primary email address is ******@fulcrumtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mel Hayes work for?

Mel Hayes is a Chief Operating Officer at Fulcrum Therapeutics, a company specializing in Commercial physical research.

Where Mel Hayes graduated from?

Mel Hayes holds a degree in General Managment, Finance, Marketing from Columbia University - Columbia Business School.

How can I directly contact Mel Hayes?

To contact Mel Hayes directly, you can use the email address ******@fulcrumtx.com. Complete contact information is available upon registration with Muraena.

Who is Mel Hayes?

Mel Hayes is a seasoned Executive Leader with over 25 years of experience in the biotechnology and pharmaceutical industries. Currently serving as the Chief Operating Officer at Fulcrum Therapeutics, Mel has a proven track record in corporate strategy, commercial operations, and product launch across multiple therapeutic areas including hematology, cardiology, and neurology. With an MBA from Columbia University, Mel combines strong business acumen with deep technical knowledge, having successfully managed top-line revenue of specialty businesses exceeding $1.5 billion. Mel is known for fostering purpose-driven cultures and building diverse teams that excel in cross-functional collaboration. His strategic insights have driven success in both U.S. and global markets, making him a key player in the commercialization of innovative therapies. Beyond his professional achievements, Mel is passionate about mentoring emerging leaders in the biotech sector and advancing healthcare accessibility.

Mel`s contact details

mail

******@fulcrumtx.com

*********@bayer.com

*********@baxalta.com

Colleagues

avatar
Pamela Mcgowan

Vice President, Head of Talent Acquisition & People Experience

avatar
Bobby Riehle

Vice President, Head of Strategy & Program Lead

avatar
Kate Haviland

Chief Executive Officer

avatar
Christine Clemson

SVP, Head of Medical Affairs

Marie-Helene Jouvin

Vice President

avatar
Helge Reisch

Vice President Drug Substance Process Development

avatar
Brian Lucas

Vice President, Head of Medicinal Chemistry

avatar
Jeff Jacobs

Chief Scientific Officer and Head of Technical Operations

Utpal Gupta

Vice President Drug Safety & Pharmacovigilance

avatar
Alan Musso

Chief Financial Officer

View Contact details (it's free)
Request Profile Removal